Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive factors of lack of response to antiviral therapy among in patients with recurrent hepatitis C after liver transplantation.

Transplantation proceedings - 1 May 2010

Marino M, Iemmolo R M, Montalti R, Bertolotti M, Di Benedetto F, De Ruvo N, Cautero N, Guerrini G, De Blasiis M G, Gerunda G E

Abstract excerpt

The current therapy for hepatitis C recurrence after liver transplantation OLT is based on interferon (IFN) and ribavirin (RBV) in monotherapy or combination. The rate of sustained virological response (SVR) varies between 10% and 45%. We have retrospectively analyzed factors that could predict S...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Aspartate Aminotransferases
Share to Body Mass Index

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Liver Transplantation

Share to Predictive Value of Tests

Share to Tissue Donors

Share to Treatment Failure

Source

Identifiers

PMID: 20534266
DOI: 10.1016/j.transproceed.2010.03.052

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20534266-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive factors of lack of response to antiviral therapy among in patients with recurrent hepatitis C after liver transplantation.PMID 20534266Read ↗

Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome.Semantic proximity Read ↗

Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation.Semantic proximity Read ↗

Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1.Semantic proximity Read ↗

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?Semantic proximity Read ↗

Recurrent hepatitis C following liver transplant: diagnosis, natural history, and therapeutic options.Semantic proximity Read ↗

Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation.Semantic proximity Read ↗

Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.Semantic proximity Read ↗

Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.Semantic proximity Read ↗

Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome.Semantic proximity Read ↗

Predictors of disease recurrence post living donor liver transplantation in end stage chronic HCV patients.Semantic proximity Read ↗

Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation.Semantic proximity Read ↗

Hepatitis C virus genotypes and severe hepatitis C virus recurrence after liver transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.